Received: 17 March 2017
Accepted: 22 January 2018
First Online: 5 February 2018
Ethics approval and consent to participate
: The current study was approved, and patient consent was waived according to regulatory review requirements, as set forth in section 46.101 (b) of 45 CFR 46, by the following institutional review boards:UnorderedList removed
: Not applicable
: JSZ, BRG, SL, RCG, MDF, ARM, DMP, JTV, JDW and PG have previously served as paid consultants to Castle Biosciences, Inc. SIE serves as a paid clinical consultant to Castle Biosciences, Inc. RWC, BM, KRC and KMP are employees of Castle Biosciences, Inc. and hold stock options. All remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.